NCT06841848 · RECRUITING

Fundus Camera Module for Early Detection of Alzheimer's Disease

This study tests a camera device that takes detailed, multi-color pictures of the back of the eye. Researchers want to see whether those images can help spot Alzheimer's earlier. They are comparing people already diagnosed with mild to moderate Alzheimer's against people without it. No phase is listed, and this is a screening tool test, not a treatment.

Eligibility criteria

Inclusion Criteria:
* 55 years or older
* Diagnosis:
  1. For AD group: Clinically diagnosed with Alzheimer's disease (mild to moderate stage) based on Mini-Mental State Examination (MMSE) score between 10-26 and confirmed by PET imaging or CSF.
  2. For Control group: No diagnosis of Alzheimer's disease or other neurodegenerative disorders.
* Signed informed consent by the patient. If there are any doubts that the patient is mentally capable of giving informed consent, the patient will be examined and verified to be mentally capable by an independent physician/ neurologist, prior to the initiation of any study specific procedure
Exclusion Criteria:
* Severe cognitive impairment (MMSE \<10) preventing cooperation during the imaging process.
* Inability to remain still during the fundus imaging procedure.

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2025-02-24

View full record on ClinicalTrials.gov

All APOE4 clinical trials